Phase 3 Trial of Nemolizumab in Patients with Prurigo NodularisShawn G. Kwatra, Sonja Ständer, Marjolein de Bruin‐Weller et al.|New England Journal of Medicine|2023Cited by 184
Efficacy and Safety of Lebrikizumab in Combination With Topical Corticosteroids in Adolescents and Adults With Moderate-to-Severe Atopic DermatitisEric L. Simpson, Brad Glick, Melinda Gooderham et al.|JAMA Dermatology|2023Cited by 148
A phase 3 open-label, randomized multicenter study to evaluate efficacy and safety of secukinumab in pediatric patients with moderate to severe plaque psoriasis: 24-week resultsNina Magnolo, Manmath Patekar, Külli Kingo et al.|Journal of the American Academy of Dermatology|2021Cited by 50
Efficacy of Secukinumab Across Subgroups and Overall Safety in Pediatric Patients with Moderate to Severe Plaque Psoriasis: Week 52 Results from a Phase III Randomized StudyNina Magnolo, Manmath Patekar, Külli Kingo et al.|Pediatric Drugs|2022Cited by 19